Understanding Higher Risk MDS and the Transition to AML 2021 Winter Patient Family Conference | Aplastic Anemia and MDS International Foundation (AAMDSIF) Return to top.

Understanding Higher Risk MDS and the Transition to AML 2021 Winter Patient Family Conference

  1. Home
Presenter(s): 
Dale Schaar, MD, PhD
Topic(s): 
Myelodysplastic Syndromes (MDS)
Acute Myeloid Leukemia (AML)
Presentation Date: 
Sat, 11/13/2021 - 11:30am (EST)

This session will provide a comprehensive overview of high risk MDS and the transition to MDS, from diagnosis to treatment.